New York State Common Retirement Fund Has $38.01 Million Position in STERIS plc (NYSE:STE)

Posted by Defense World Staff on Apr 14th, 2023

New York State Common Retirement Fund reduced its stake in STERIS plc (NYSE:STE – Get Rating) by 3.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 205,784 shares of the medical equipment provider’s stock after selling 8,324 shares during the period. New York State Common Retirement Fund owned 0.21% of STERIS worth $38,006,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of STE. Yousif Capital Management LLC increased its holdings in shares of STERIS by 0.7% in the first quarter. Yousif Capital Management LLC now owns 15,327 shares of the medical equipment provider’s stock valued at $3,706,000 after purchasing an additional 106 shares during the last quarter. Vontobel Holding Ltd. increased its holdings in shares of STERIS by 25.6% in the first quarter. Vontobel Holding Ltd. now owns 1,919 shares of the medical equipment provider’s stock valued at $471,000 after purchasing an additional 391 shares during the last quarter. Blair William & Co. IL increased its holdings in shares of STERIS by 8.1% in the first quarter. Blair William & Co. IL now owns 13,523 shares of the medical equipment provider’s stock valued at $3,269,000 after purchasing an additional 1,010 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of STERIS by 24.4% in the first quarter. Cetera Investment Advisers now owns 2,345 shares of the medical equipment provider’s stock valued at $567,000 after purchasing an additional 460 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of STERIS by 1.3% in the first quarter. Vanguard Group Inc. now owns 11,525,769 shares of the medical equipment provider’s stock valued at $2,786,586,000 after purchasing an additional 143,253 shares during the last quarter. 92.35% of the stock is currently owned by institutional investors and hedge funds.

STERIS Trading Up 0.8 %

STE opened at $195.12 on Friday. STERIS plc has a twelve month low of $159.21 and a twelve month high of $255.93. The company has a 50-day simple moving average of $189.72 and a 200 day simple moving average of $184.42. The company has a quick ratio of 1.61, a current ratio of 2.48 and a debt-to-equity ratio of 0.50.

STERIS (NYSE:STE – Get Rating) last posted its quarterly earnings data on Wednesday, February 8th. The medical equipment provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.19 by ($0.17). STERIS had a positive return on equity of 12.86% and a negative net margin of 0.58%. The firm had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the company earned $2.12 EPS. The company’s revenue for the quarter was up .8% compared to the same quarter last year. On average, research analysts predict that STERIS plc will post 8.05 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 23rd. Investors of record on Friday, February 24th were given a dividend of $0.47 per share. The ex-dividend date was Thursday, February 23rd. This represents a $1.88 annualized dividend and a yield of 0.96%. STERIS’s dividend payout ratio is -648.25%.

Analyst Ratings Changes

Several equities analysts have commented on STE shares. Stephens reiterated an “overweight” rating and issued a $220.00 price objective on shares of STERIS in a report on Thursday, February 9th. Piper Sandler decreased their price target on shares of STERIS from $235.00 to $215.00 and set an “overweight” rating on the stock in a research note on Thursday, February 9th. TheStreet downgraded shares of STERIS from a “b-” rating to a “c+” rating in a research note on Wednesday, March 1st. JMP Securities decreased their price target on shares of STERIS from $250.00 to $240.00 and set a “market outperform” rating on the stock in a research note on Wednesday, February 15th. Finally, StockNews.com initiated coverage on shares of STERIS in a research note on Thursday, March 16th. They issued a “buy” rating on the stock. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $224.40.

About STERIS

(Get Rating)

STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites.